参与 NGLY1 缺乏症的 SCFFBS2 泛素连接酶识别糖的结构基础

IF 3.5 4区 生物学 Q1 Biochemistry, Genetics and Molecular Biology
Tadashi Satoh, Maho Yagi-Utsumi, Nozomi Ishii, Tsunehiro Mizushima, Hirokazu Yagi, Ryuichi Kato, Yuriko Tachida, Hiroaki Tateno, Ichiro Matsuo, Koichi Kato, Tadashi Suzuki, Yukiko Yoshida
{"title":"参与 NGLY1 缺乏症的 SCFFBS2 泛素连接酶识别糖的结构基础","authors":"Tadashi Satoh,&nbsp;Maho Yagi-Utsumi,&nbsp;Nozomi Ishii,&nbsp;Tsunehiro Mizushima,&nbsp;Hirokazu Yagi,&nbsp;Ryuichi Kato,&nbsp;Yuriko Tachida,&nbsp;Hiroaki Tateno,&nbsp;Ichiro Matsuo,&nbsp;Koichi Kato,&nbsp;Tadashi Suzuki,&nbsp;Yukiko Yoshida","doi":"10.1002/1873-3468.15003","DOIUrl":null,"url":null,"abstract":"<p>The cytosolic peptide:<i>N</i>-glycanase (PNGase) is involved in the quality control of <i>N</i>-glycoproteins via the endoplasmic reticulum-associated degradation (ERAD) pathway. Mutations in the gene encoding cytosolic PNGase (<i>NGLY1</i> in humans) cause NGLY1 deficiency. Recent findings indicate that the F-box protein FBS2 of the SCF<sup>FBS2</sup> ubiquitin ligase complex can be a promising drug target for NGLY1 deficiency. Here, we determined the crystal structure of bovine FBS2 complexed with the adaptor protein SKP1 and a sugar ligand, Man<sub>3</sub>GlcNAc<sub>2</sub>, which corresponds to the core pentasaccharide of <i>N</i>-glycan. Our crystallographic data together with NMR data revealed the structural basis of disparate sugar-binding specificities in homologous FBS proteins and identified a potential druggable pocket for <i>in silico</i> docking studies. Our results provide a potential basis for the development of selective inhibitors against FBS2 in NGLY1 deficiency.</p>","PeriodicalId":12142,"journal":{"name":"FEBS Letters","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Structural basis of sugar recognition by SCFFBS2 ubiquitin ligase involved in NGLY1 deficiency\",\"authors\":\"Tadashi Satoh,&nbsp;Maho Yagi-Utsumi,&nbsp;Nozomi Ishii,&nbsp;Tsunehiro Mizushima,&nbsp;Hirokazu Yagi,&nbsp;Ryuichi Kato,&nbsp;Yuriko Tachida,&nbsp;Hiroaki Tateno,&nbsp;Ichiro Matsuo,&nbsp;Koichi Kato,&nbsp;Tadashi Suzuki,&nbsp;Yukiko Yoshida\",\"doi\":\"10.1002/1873-3468.15003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The cytosolic peptide:<i>N</i>-glycanase (PNGase) is involved in the quality control of <i>N</i>-glycoproteins via the endoplasmic reticulum-associated degradation (ERAD) pathway. Mutations in the gene encoding cytosolic PNGase (<i>NGLY1</i> in humans) cause NGLY1 deficiency. Recent findings indicate that the F-box protein FBS2 of the SCF<sup>FBS2</sup> ubiquitin ligase complex can be a promising drug target for NGLY1 deficiency. Here, we determined the crystal structure of bovine FBS2 complexed with the adaptor protein SKP1 and a sugar ligand, Man<sub>3</sub>GlcNAc<sub>2</sub>, which corresponds to the core pentasaccharide of <i>N</i>-glycan. Our crystallographic data together with NMR data revealed the structural basis of disparate sugar-binding specificities in homologous FBS proteins and identified a potential druggable pocket for <i>in silico</i> docking studies. Our results provide a potential basis for the development of selective inhibitors against FBS2 in NGLY1 deficiency.</p>\",\"PeriodicalId\":12142,\"journal\":{\"name\":\"FEBS Letters\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FEBS Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/1873-3468.15003\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEBS Letters","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/1873-3468.15003","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

摘要

细胞膜肽:N-糖酶(PNGase)通过内质网相关降解(ERAD)途径参与 N-糖蛋白的质量控制。编码细胞膜 PNG 酶(人类为 NGLY1)的基因突变会导致 NGLY1 缺乏症。最近的研究结果表明,SCFFBS2 泛素连接酶复合物中的 F-box 蛋白 FBS2 可作为治疗 NGLY1 缺乏症的药物靶点。在这里,我们测定了牛 FBS2 与适配蛋白 SKP1 和糖配体 Man3GlcNAc2 复合物的晶体结构。我们的晶体学数据和核磁共振数据揭示了同源 FBS 蛋白不同糖结合特异性的结构基础,并为硅对接研究确定了一个潜在的药物口袋。我们的研究结果为开发针对 NGLY1 缺乏症的 FBS2 的选择性抑制剂提供了潜在的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Structural basis of sugar recognition by SCFFBS2 ubiquitin ligase involved in NGLY1 deficiency

Structural basis of sugar recognition by SCFFBS2 ubiquitin ligase involved in NGLY1 deficiency

The cytosolic peptide:N-glycanase (PNGase) is involved in the quality control of N-glycoproteins via the endoplasmic reticulum-associated degradation (ERAD) pathway. Mutations in the gene encoding cytosolic PNGase (NGLY1 in humans) cause NGLY1 deficiency. Recent findings indicate that the F-box protein FBS2 of the SCFFBS2 ubiquitin ligase complex can be a promising drug target for NGLY1 deficiency. Here, we determined the crystal structure of bovine FBS2 complexed with the adaptor protein SKP1 and a sugar ligand, Man3GlcNAc2, which corresponds to the core pentasaccharide of N-glycan. Our crystallographic data together with NMR data revealed the structural basis of disparate sugar-binding specificities in homologous FBS proteins and identified a potential druggable pocket for in silico docking studies. Our results provide a potential basis for the development of selective inhibitors against FBS2 in NGLY1 deficiency.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
FEBS Letters
FEBS Letters 生物-生化与分子生物学
CiteScore
7.00
自引率
2.90%
发文量
303
审稿时长
1.0 months
期刊介绍: FEBS Letters is one of the world''s leading journals in molecular biology and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, Research Letters and Hypotheses that merit urgent publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信